Celgene (CELG) PT, Estimates Raised at Jefferies on 'Robust' Q3
Tweet Send to a Friend
Jefferies analyst Thomas Wei boosted his price target on Celgene (NASDAQ: CELG) from $161 to $185 following "robust" 3Q earnings ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
